GlassScriptPhysician profile
Thomas J Cachur
NPI 1225037047
$2,577.43
in general payments reported to CMS, 2019-2025
19 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $294 · 2021: $282 · 2022: $418 · 2023: $488 · 2024: $342 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $461.51 | 2019-2022 | |
| Organon LLC | $435.73 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $376.79 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sumitomo Pharma America, INC. | $369.88 | 2023-2025 | Myfembree |
| Davol INC. | $148.40 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $143.57 | 2019-2023 | |
| Coopersurgical, INC. | $143.47 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Sage Therapeutics, LLC | $80.15 | 2025 | Zurzuvae |
| Sanofi Pasteur INC. | $76.02 | 2019-2023 | |
| Myovant Sciences INC. | $69.22 | 2021-2022 | |
| Baxter Healthcare | $49.07 | 2024 | Perclot |
| Glaxosmithkline, LLC. | $44.71 | 2021-2023 | Pediarix, Rotarix, Bexsero |
| Hologic Sales and Service, LLC | $41.01 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $34.70 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $26.06 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.42 | 2025 | Mounjaro, Zepbound |
| Sobi, INC | $19.97 | 2021 | |
| Boston Scientific Corporation | $19.80 | 2019 | |
| Phadia US INC. | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cachur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.